{
  "id": "f9461bf39917ed55",
  "title": "STAT+: On Day 3 of JPM, pharma threads a needle with the White House, and Novo Nordisk has an eye on M&A",
  "description": "Some analysts believe both the White House and drugmakers won in the standoff over drug prices. Sanofi CEO Paul Hudson isn't so sure.",
  "content": "Some analysts believe both the White House and drugmakers won in the standoff over drug prices. Sanofi CEO Paul Hudson isn't so sure.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/14/jpm-2026-day-3-top-stories-sanofi-bms-pfizer-biontech/?utm_campaign=rss",
  "published_at": "2026-01-14T21:01:32+00:00",
  "fetched_at": "2026-01-15T00:21:56.842948+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: On Day 3 of JPM, pharma threads a needle with the White House, and Novo Nordisk has an eye on M&A",
    "description": "Some analysts believe both the White House and drugmakers won in the standoff over drug prices. Sanofi CEO Paul Hudson isn't so sure.",
    "url": "https://www.statnews.com/2026/01/14/jpm-2026-day-3-top-stories-sanofi-bms-pfizer-biontech/?utm_campaign=rss",
    "published": "2026-01-14T21:01:32+00:00",
    "source": "STAT"
  }
}